Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$488,427
-$85,364 QoQ
Shares Held
38,672
+6.3% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IEQ CAPITAL, LLC holds $233,746,766 across 77 Biotechnology names. ENTA ranks #38 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,302 | $60,499,257 | |
| 2 | INCY |
Incyte Corp
|
498,835 | $46,950,350 | |
| 3 | EXEL |
Exelixis, Inc.
|
579,541 | $24,856,513 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
401,610 | $22,686,948 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,175 | $12,134,723 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
370,481 | $8,061,666 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
22,871 | $7,567,327 | |
| 8 | RPRX |
Royalty Pharma plc
|
104,778 | $5,026,200 |
All Filings in ENTA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $488,427 | 38,672 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $573,791 | 36,385 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $451,101 | 37,686 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $305,030 | 40,348 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $231,823 | 41,997 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||